IT8347978A0 - Agente farmaceutico per il trattamento di tumori in fase di metastatizzazione e di anemie da labilita'della membrana eritrocitaria - Google Patents

Agente farmaceutico per il trattamento di tumori in fase di metastatizzazione e di anemie da labilita'della membrana eritrocitaria

Info

Publication number
IT8347978A0
IT8347978A0 IT8347978A IT4797883A IT8347978A0 IT 8347978 A0 IT8347978 A0 IT 8347978A0 IT 8347978 A IT8347978 A IT 8347978A IT 4797883 A IT4797883 A IT 4797883A IT 8347978 A0 IT8347978 A0 IT 8347978A0
Authority
IT
Italy
Prior art keywords
metastatizing
lability
tumors
phase
treatment
Prior art date
Application number
IT8347978A
Other languages
English (en)
Other versions
IT1170342B (it
Inventor
Materazzi Mario
Camilloni Giorgio
De Luca Giovanna
Di Stazio Giovan-Ni
Politi Vincenzo
Original Assignee
Polifarma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polifarma Spa filed Critical Polifarma Spa
Priority to IT47978/83A priority Critical patent/IT1170342B/it
Publication of IT8347978A0 publication Critical patent/IT8347978A0/it
Priority to DE3410848A priority patent/DE3410848C2/de
Application granted granted Critical
Publication of IT1170342B publication Critical patent/IT1170342B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT47978/83A 1983-03-24 1983-03-24 Agente farmaceutico per il trattamento di tumori in fase di metastatizzazione e di anemie da labilita' della membrana eritrocitaria IT1170342B (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT47978/83A IT1170342B (it) 1983-03-24 1983-03-24 Agente farmaceutico per il trattamento di tumori in fase di metastatizzazione e di anemie da labilita' della membrana eritrocitaria
DE3410848A DE3410848C2 (de) 1983-03-24 1984-03-23 Verwendung von Flunarizin zur Behandlung von Tumoren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT47978/83A IT1170342B (it) 1983-03-24 1983-03-24 Agente farmaceutico per il trattamento di tumori in fase di metastatizzazione e di anemie da labilita' della membrana eritrocitaria

Publications (2)

Publication Number Publication Date
IT8347978A0 true IT8347978A0 (it) 1983-03-24
IT1170342B IT1170342B (it) 1987-06-03

Family

ID=11263744

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47978/83A IT1170342B (it) 1983-03-24 1983-03-24 Agente farmaceutico per il trattamento di tumori in fase di metastatizzazione e di anemie da labilita' della membrana eritrocitaria

Country Status (2)

Country Link
DE (1) DE3410848C2 (it)
IT (1) IT1170342B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8914060D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
WO1990015599A1 (en) * 1989-06-19 1990-12-27 The Wellcome Foundation Limited Medicaments useful in cancer therapy and having antihistaminic properties
GB8914040D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914061D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance

Also Published As

Publication number Publication date
IT1170342B (it) 1987-06-03
DE3410848A1 (de) 1984-09-27
DE3410848C2 (de) 1987-02-05

Similar Documents

Publication Publication Date Title
FR2523443B1 (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
IT1190466B (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
DK195988D0 (da) Farmaceutisk praeparat indeholdende mikrokapsler
PT81969A (de) 11beta-phenyl-gonane deren herstellung und diese enthaltende pharmazeutische praparate
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
IT1235532B (it) Composti carbossiammidici, procedimenti per la preparazione dei medesimi e composizione farmaceutica contenente i medesimi
PT87237A (pt) Process for the preparation of bifunctional proteins and of pharmaceutical compounds containing them
IT1150608B (it) Complessi platino-diamminici e procedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi
PT83896A (fr) Procede pour la preparation de nouveaux conjuges de la vinblas-tine et de ses derives et de compositions pharmaceutiques les contenant
IT1183181B (it) Derivati del 3-metil-imidazo(4,5-c)pirazolo con attivita' terapeutica e procedimento per la loropreparazione
FR2607502B1 (fr) Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
IL84168A0 (en) Human factor viii-c analogs,process for the preparation thereof and pharmaceutical compositions containing the same
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
IT8347978A0 (it) Agente farmaceutico per il trattamento di tumori in fase di metastatizzazione e di anemie da labilita'della membrana eritrocitaria
IT1151953B (it) Composizione farmaceutica per la cura di affezioni della cavita' orale
DK515285A (da) Imidazoliumsalte med blodsukker-saenkende virkning og farmaceutiske midler indeholdende saadanne forbindelser
DK99085A (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
DK624587D0 (da) Farmaceutisk praeparat indeholdende imidazolderivater
FR2639946B1 (fr) Peptides contenant de l'imidazole, leurs procedes de preparation et compositions pharmaceutiques les contenant
DK415087A (da) Terapeutiske midler indeholdende benzhydrylthiomethanderivater
IT1196494B (it) Derivati dell'acito cef-3-em-4-carbossilico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
DK52186D0 (da) Farmaceutisk praeparat indeholdende indolderivater
IT1203976B (it) Derivati dell'ergolene, composizioni farmaceutiche che li contengono e procedimento per la preparazione dei medesimi